Over 31 mln doses of COVID-19 vaccine administered in China
- Share
BEIJING -- More than 31 million doses of COVID-19 vaccine had been administered in China as of Feb. 3, according to China's National Health Commission.
Preliminary tests showed that the incidence of severe abnormal reactions caused by the COVID-19 vaccines currently used in China is no higher than that of the influenza vaccine, said Xu Wenbo, head of the National Institute for Viral Disease Control and Prevention under the Chinese Center for Disease Control and Prevention.
In late December 2020, an inactivated vaccine developed by Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm, became the first to receive conditional market approval from the National Medical Products Administration.
Produced by Xinhua Global Service
